Across healthcare, digital technology had started to significantly change the way patients experience their care, how healthcare professionals practice medicine, and how companies like UCB develop solutions and bring them to the market. That is why UCB is undergoing our own digital business transformation (DBT).
 
Through DBT, we are improving the way business gets done at UCB to be faster and better. We want to establish a data-centric culture where data is each of our responsibility, informs decision making and amplifies value creation. This is done by leveraging new digital tools and techniques (e.g., advanced analytics and artificial intelligence), disrupting the status quo through new digital platforms and infrastructure, and strategic partnerships and investments.  
 
As part of that ambition, UCB and Aetion announced a new agreement to advance UCB’s use of real-world evidence (RWE) using rapid and robust analytics. The evidence generated will enhance the development and evolution of UCB’s value proposition while providing key insights and data to support value-based contracting agreements across UCB’s portfolio within the U.S. market.

The relationship informs health economics and outcomes research (HEOR) and U.S. market access strategy across both UCB’s immunology and neurology teams to support patient access and will further the company’s mission to transform the lives of people living with severe diseases 

“As UCB goes through our digital business transformation, we believe that strategic partnerships will advance our capabilities for rapid analytics in assessing unmet patient needs in the real-world to develop medicines for patients faster,” said Emmanuel Caeymaex, Executive Vice President of Immunology Solutions & Head of U.S. at UCB. “Our agreement with Aetion has allowed us to expedite the time it takes to analyze available health data and generate critical insights so that we can better understand the value our solutions bring to patients and payers as we engage in value-based contracting.” 

As UCB continues to accelerate digitalization, this agreement enhances UCB’s ambition to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want so that we can continue to bring value to patients in a way that is sustainable now, and in the future.